Chesapeake Corp

Chesapeake — Shareholder Meeting (April 2008)

19 slides from Chesapeake's shareholder meeting presentation, Apr 24, 2008

  1. Slide 1: Chesapeake Annual Meeting April 23, 2008

    Chesapeake Annual Meeting April 23, 2008

  2. Slide 2: Leading Market Positions

    Chesapeake Leading Market Positions • Pharmaceutical and healthcare packaging in Europe • Specialty chemicals packaging in Europe • Confectionery packaging in Germany and the U.K. • Alcoholic drinks packaging in Europe • Irish dairy packaging

  3. Slide 3: Pharmaceuticals, Specialty Plastics, Branded Products

    Pharmaceuticals Specialty Plastics Branded Products We Protect and Promote the World’s Great Brands

  4. Slide 4: Financial Summary

    $ in millions, except EPS ¹ Excludes special items Financial Summary 2006 2007 Sales $ 995.4 $1,059.6 Operating Income¹ 44.9 41.0 Income (loss) from continuing operations¹ 7.0 (1.9) EPS¹ $ 0.36 $ (0.10)

  5. Slide 5: Three Focus Areas

    Three Focus Areas • Operational • Strategic • Structural

  6. Slide 6: Three Focus Areas: Operational Issues

    Three Focus Areas 1 . Operational Issues – $25-million cost savings program launched in 2006 – Reached initial target in 2007 but cost reduction and rationalization efforts continue – Continued focus on fundamentals • Discovered practices to save $400K/year in Belfast

  7. Slide 7: Three Focus Areas: Strategic Direction

    Three Focus Areas 2. Strategic Direction – Pharmaceutical and Healthcare Packaging • Ethical and generic prescription medicines • Over-the-counter (OTC) medicines • Healthcare products • Medical devices • Toiletries – Branded Products Packaging • Alcoholic drinks and confectioneries – Plastic Packag

  8. Slide 8: Global Reach with Local Touch

    “Global Reach with Local Touch” Pharmaceutical and Healthcare Packaging • Ties to majority of Top 20 global pharmaceutical companies • Expect 5 percent annual growth in worldwide pharma packaging • Twenty-five dedicated sites in U.S., Europe and Asia

  9. Slide 9: Pharmaceutical and Healthcare Packaging

    Pharmaceutical and Healthcare Packaging • Intend to leverage position and expand geographically into S.E. Asia, Poland, India, Puerto Rico and South America • New five-year supply agreement with GSK or new weight-loss product • First and only pharma plant in China to earn S9000 certification

  10. Slide 10: First Plant in China with PS9000 Certification

    First Plant in China with PS9000 Certification

  11. Slide 11: Looking Ahead

    Looking Ahead • Targeting 8 percent earnings growth and EBITDA margins of 15 percent • Shifting our footprint eastward and increasing presence in emerging markets • Believe we can increase sales dramatically to pharmaceutical and healthcare customers

  12. Slide 12: New Developments - Plastic Packaging Plant in Hungary

    New Developments -- Plastic Packaging Plant in Hungary

  13. Slide 13: New Developments - Consolidated Carton, Tubes and Labels in Scotland

    New Developments - Consolidated Carton, Tubes and Labels for Alcoholic Drinks in Scotland

  14. Slide 14: New Developments - Anti-Static Container

    New Developments - Anti-Static Container

  15. Slide 15: Three Focus Areas: Financial Structure

    Three Focus Areas 3. Financial Structure – Debt level and refinancing uncertainty have hurt our stock and bond prices – Significant progress made on refinancing – Focus on pension obligations • Frozen or closed most defined benefit plans • U.K. pension plan is under-funded

  16. Slide 16: We Protect and Promote the World's Great Brands

    We Protect and Promote the World’s Great Brands

  17. Slide 17: Disclaimer

    Disclaimer This presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause Chesapeake's ac

  18. Slide 18: Reconciliation of Non-GAAP Financial Measures

    Disclaimer Full Year 2007 2006 RECONCILIATION OF NON-GAAP FINANCIAL MEASURES ($ in millions) Operating (loss) income $ 26.7 $ 0.3 Add: goodwill impairment charge - -- 14.3 Add: restructuring expenses, asset impairments and other exit costs 15.8 33.4 Add: (gain) loss on divestitures (1.5) (3.1) Opera

  19. Slide 19: Chesapeake Annual Meeting April 23, 2008

    Chesapeake Annual Meeting April 23, 2008

Chesapeake — Shareholder Meeting (April 2008) on 6ix